Annovis Bio says updated Alzheimer’s trial protocol accepted by FDA
Annovis Bio (NYSE:ANVS) announced Tuesday that the U.S. Food and Drug Administration (FDA) accepted an updated protocol for a ...
The Brighterside of News on MSN20m
Aging plays a new role in the fight against Alzheimer's disease
The balance of protein health within cells, a process known as proteostasis, is critical for maintaining cellular ...